TBHQ
Based on 123 publication(s) in Google Scholar
TBHQ (tert-Butylhydroquinone) is a widely used Nrf2 activator, protects against Doxorubicin (DOX)-induced cardiotoxicity through activation of Nrf2. TBHQ (tert-Butylhydroquinone) is also an ERK activator; rescues Dehydrocorydaline (DHC)-induced cell proliferation inhibitionin melanoma.
Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.
- Reinheit: 99.86%
- CAS. Nr.: 1948-33-0
- Formel: C10H14O2
- Molecular Weight:166.22
-
Speicherung:
Store at room temperature 3 years.
In solvent -80°C, 2 years , -20°C, 1 year
Publications Citing Use of MedChemExpress (MCE) TBHQ
More- Nat Commun. 2025 Mar 4;16(1):2192. [Abstract]
- Nat Commun. 2023 May 13;14(1):2756. [Abstract]
- Nat Commun. 2023 Apr 10;14(1):2004. [Abstract]
- Autophagy. 2025 Feb;21(2):407-423. [Abstract]
- Adv Sci (Weinh). 2025 May 23:e04372. [Abstract]
- Theranostics. 2021 Jan 1;11(2):861-877. [Abstract]
- Chem Eng J. 2025 Oct 15.
- J Adv Res. 2025 Mar:69:545-563. [Abstract]
- J Nanobiotechnology. 2022 Jun 11;20(1):270. [Abstract]
- Sci Adv. 2025 Dec 19;11(51):eady2104. [Abstract]
- Redox Biol. 2025 Nov:87:103886. [Abstract]
- Redox Biol. 2025 Aug 6:86:103815. [Abstract]
- Redox Biol. 2025 Oct:86:103804. [Abstract]
- Redox Biol. 2022 Jul 31;55:102408. [Abstract]
- J Immunother Cancer. 2025 Jan 4;13(1):e010183. [Abstract]
- Pharmacol Res. 2024 Jun 28:107252. [Abstract]
- J Neuroinflammation. 2019 Oct 4;16(1):185. [Abstract]
- Int J Biol Sci. 2022 Oct 24;18(16):6189-6209. [Abstract]
- Cell Death Dis. 2025 Apr 9;16(1):266. [Abstract]
- Cell Death Dis. 2024 Dec 1;15(12):873. [Abstract]
- Cell Death Dis. 2023 Feb 10;14(2):100. [Abstract]
- Cell Death Dis. 2022 Aug 25;13(8):733. [Abstract]
- J Cachexia Sarcopenia Muscle. 2025 Aug;16(4):e70004. [Abstract]
- Proc Natl Acad Sci U S A. 2019 Feb 19;116(8):2996-3005. [Abstract]
- Cell Commun Signal. 2025 Feb 21;23(1):104. [Abstract]
- Int J Biol Macromol. 2025 Apr 9:143030. [Abstract]
- Int J Biol Macromol. 2024 Aug 16:134815. [Abstract]
- Int J Biol Macromol. 2024 May;266(Pt 1):130939. [Abstract]
- Acta Pharmacol Sin. 2024 Oct;45(10):2174-2185. [Abstract]
- Phytomedicine. 2024 May 10:130:155696. [Abstract]
- Phytomedicine. 2023 Oct:119:154992. [Abstract]
- Phytomedicine. 2022 Jun;100:154084. [Abstract]
- Free Radic Biol Med. 2025 Aug 11:240:238-252. [Abstract]
- Free Radic Biol Med. 2024 Mar:214:115-128. [Abstract]
- Free Radic Biol Med. 2024 Mar:213:190-207. [Abstract]
- Free Radic Biol Med. 2023 May 1:200:26-35. [Abstract]
- Regen Biomater. 2024 Apr 16:11:rbae042. [Abstract]
- NPJ Sci Food. 2026 Feb 7;10(1):94. [Abstract]
- Br J Pharmacol. 2024 Dec;181(23):4845-4858. [Abstract]
- Environ Res. 2024 May 8;252(Pt 4):119113. [Abstract]
- J Transl Med. 2023 Oct 30;21(1):766. [Abstract]
- Biomed Pharmacother. 2022 Aug:152:113117. [Abstract]
- Redox Rep. 2025 Dec;30(1):2503130. [Abstract]
- Int J Radiat Oncol Biol Phys. 2023 Dec 1;117(5):1241-1254. [Abstract]
- J Agric Food Chem. 2025 Oct 24. [Abstract]
- Cell Mol Life Sci. 2024 Jun 25;81(1):278. [Abstract]
- J Agric Food Chem. 2021 Sep 15;69(36):10606-10616. [Abstract]
- Ecotoxicol Environ Saf. 2026 Jan 1:309:119697. [Abstract]
- Ecotoxicol Environ Saf. 2023 May:256:114889. [Abstract]
- Cell Prolif. 2025 Jan 6:e13799. [Abstract]
- Biochem Pharmacol. 2020 Mar;173:113673. [Abstract]
- J Dent. 2025 Apr 28:105787. [Abstract]
- J Ethnopharmacol. 2024 May 10:325:117755. [Abstract]
- J Ethnopharmacol. 2024 Mar 1:321:117421. [Abstract]
- Microchem J. 2026 Mar 5.
- Drug Des Devel Ther. 2023 Feb 20:17:535-550. [Abstract]
- Life Sci. 2021 Nov 15:285:119963. [Abstract]
- Int J Mol Sci. 2023 Sep 18;24(18):14215. [Abstract]
- Int J Mol Sci. 2022 Dec 21;24(1):73. [Abstract]
- Pharm Biol. 2022 Dec;60(1):729-742. [Abstract]
- Front Pharmacol. 2018 Jun 6:9:540. [Abstract]
- Int Immunopharmacol. 2025 Nov 8;168(Pt 1):115798. [Abstract]
- Int Immunopharmacol. 2025 Oct 19:167:115676. [Abstract]
- Int Immunopharmacol. 2024 Jun 24:138:112515. [Abstract]
- Int Immunopharmacol. 2023 Jul:120:110371. [Abstract]
- Int Immunopharmacol. 2023 Feb:115:109716. [Abstract]
- Molecules. 2023 Nov 25;28(23):7776. [Abstract]
- J Inflamm Res. 2025 Mar 20:18:4233-4250. [Abstract]
- J Inflamm Res. 2024 Oct 25:17:7705-7719. [Abstract]
- J Funct Foods. 2025 May.
- Sci Rep. 2025 Jul 24;15(1):26917. [Abstract]
- Sci Rep. 2025 Jul 1;15(1):20426. [Abstract]
- J Virol. 2026 Feb 17;100(2):e0165625. [Abstract]
- ACS Infect Dis. 2025 Aug 19. [Abstract]
- Food Sci Nutr. 2025 Jan 24;13(1):e4768. [Abstract]
- Virol J. 2022 Jan 31;19(1):23. [Abstract]
- Cell Signal. 2025 Nov:135:111998. [Abstract]
- Cell Signal. 2025 Jun 27:111969. [Abstract]
- Eur J Immunol. 2023 Sep;53(9):e2350374. [Abstract]
- PLoS Comput Biol. 2026 Mar 6;22(3):e1014025. [Abstract]
- Vet Res. 2025 Dec 18;56(1):232. [Abstract]
- Mol Med Rep. 2021 Jun;23(6):428. [Abstract]
- Viruses. 2019 Jul 20;11(7):665. [Abstract]
- Toxicol Appl Pharmacol. 2024 Jun 3:116990. [Abstract]
- BMC Complement Med Ther. 2024 Apr 25;24(1):175. [Abstract]
- Nanotoxicology. 2021 Aug;15(6):779-797. [Abstract]
- Eur J Med Res. 2021 Jan 21;26(1):11. [Abstract]
- Neurotox Res. 2023 Oct;41(5):446-458. [Abstract]
- Int J Med Sci. 2022 Jan 4;19(2):286-298. [Abstract]
- Vet J. 2026 Apr:316:106599. [Abstract]
- Cancer Med. 2020 Oct;9(19):7268-7278. [Abstract]
- Mol Immunol. 2024 Mar:167:25-33. [Abstract]
- Toxicol Lett. 2022 Jul 15:365:61-73. [Abstract]
- Neuroscience. 2022 Jul 1:494:51-68. [Abstract]
- Onco Targets Ther. 2019 Jul 2:12:5163-5175. [Abstract]
- Cell Biochem Funct. 2024 Jun;42(4):e4024. [Abstract]
- PLoS One. 2023 Sep 26;18(9):e0291693. [Abstract]
- Brain Res. 2020 Jul 15;1739:146818. [Abstract]
- Cell Biochem Biophys. 2025 Jun;83(2):2023-2033. [Abstract]
- Tissue Cell. 2024 Feb:86:102294. [Abstract]
- Clin Res Hepatol Gastroenterol. 2021 Sep;45(5):101586. [Abstract]
- Int J Exp Pathol. 2025 Nov;106(6):e70008. [Abstract]
- Biochem Biophys Res Commun. 2022 Jul 23:614:47-55. [Abstract]
- Oncol Lett. 2021 Aug;22(2):609. [Abstract]
- Biochem Bioph Res Co. 2020 Dec 10;533(3):533-539. [Abstract]
- Biochem Biophys Res Commun. 2020 Jun 11;526(4):1013-1020. [Abstract]
- Biochem Biophys Res Commun. 2018 Jun 7;500(3):790-796. [Abstract]
- Eur J Histochem. 2022 Jun 21;66(3). [Abstract]
- Nat Prod Commun. 2023 Aug 16.
- J Environ Sci (China). 2026 Mar:161:201-208. [Abstract]
- Patent. US20240238358A1
- Patent. US20240238358A1.
- Patent. US20240261359A1.
- Research Square Preprint. 2023 May 23.
- Research Square Print. 2023 Mar 24.
- Research Square Print. December 7th, 2022.
- Research Square Print. December 29th, 2022.
- Research Square Preprint. 2022 Jul.
- Research Square Preprint. 2022 Jul.
- Oxid Med Cell Longev. 2022 Apr 18;2022:9304383. [Abstract]
- Oxid Med Cell Longev. 2021 Jun 9:2021:6694964. [Abstract]
- Research Square Preprint. 2021 May.
- Oxid Med Cell Longev. 2020 May 13;2020:3145182. [Abstract]
-
WB
-
RT-PCR
-
WB
-
IF
-
WB
Biologische Aktivität
|
Nrf2 |
ERK |
Autophagy |
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| HCT-116 | IC50 |
>100 μM
Compound: tBHQ
|
Cytotoxicity against human HCT116 cells by MTT assay
Cytotoxicity against human HCT116 cells by MTT assay
|
[PMID: 23820128] |
| HeLa | EC50 |
>400 μM
Compound: TBHQ
|
Inhibition of Influenza A virus H3N2 A/X-31 hemagglutinin 3 D1122N expressed in HeLa cells assessed as polykaryon formation preincubated for 15 mins and further incubated for 15 mins with acidic buffer containing compounds at pH 5.6 by giemsa staining bas
Inhibition of Influenza A virus H3N2 A/X-31 hemagglutinin 3 D1122N expressed in HeLa cells assessed as polykaryon formation preincubated for 15 mins and further incubated for 15 mins with acidic buffer containing compounds at pH 5.6 by giemsa staining bas
|
[PMID: 31753804] |
| HeLa | EC50 |
12 μM
Compound: TBHQ
|
Inhibition of Influenza A virus H3N2 A/X-31 hemagglutinin 3 E572K mutant expressed in HeLa cells assessed as polykaryon formation preincubated for 15 mins and further incubated for 15 mins with acidic buffer containing compounds at pH 5.2 by giemsa staini
Inhibition of Influenza A virus H3N2 A/X-31 hemagglutinin 3 E572K mutant expressed in HeLa cells assessed as polykaryon formation preincubated for 15 mins and further incubated for 15 mins with acidic buffer containing compounds at pH 5.2 by giemsa staini
|
[PMID: 31753804] |
| HeLa | EC50 |
9.9 μM
Compound: TBHQ
|
Inhibition of influenza H3N2 A/X-31 hemagglutinin 3 expressed in HeLa cells assessed as polykaryon formation preincubated for 15 mins and further incubated for 15 mins with acidic buffer containing compounds at pH 5.2 by giemsa staining based microscopic
Inhibition of influenza H3N2 A/X-31 hemagglutinin 3 expressed in HeLa cells assessed as polykaryon formation preincubated for 15 mins and further incubated for 15 mins with acidic buffer containing compounds at pH 5.2 by giemsa staining based microscopic
|
[PMID: 31753804] |
| HepG2 | EC50 |
12.6 μM
Compound: t-Butylhydroquinone
|
Activation of human PXR expressed in human HepG2 (DPX-2) cells after 24 hrs by luciferase reporter gene based luminescent analysis
Activation of human PXR expressed in human HepG2 (DPX-2) cells after 24 hrs by luciferase reporter gene based luminescent analysis
|
[PMID: 20966043] |
| HepG2 | EC50 |
2 μM
Compound: t-Butylhydroquinone
|
Activation of human PXR expressed in human HepG2 (DPX-2) cells assessed as induction of CYP3A4 after 24 hrs by luminescent analysis
Activation of human PXR expressed in human HepG2 (DPX-2) cells assessed as induction of CYP3A4 after 24 hrs by luminescent analysis
|
[PMID: 20966043] |
| THP-1 | IC50 |
>100 μM
Compound: tBHQ
|
Cytotoxicity against human THP-1 cells assessed as reduction in cell viability measured after 24 hrs by MTT assay
Cytotoxicity against human THP-1 cells assessed as reduction in cell viability measured after 24 hrs by MTT assay
|
[PMID: 35253427] |
TBHQ (t-butylhydroquinone; tBHQ; 0-100 μM; 48 hours; H9c2 cells) alone does not affect H9c2 cells viability. Pre-incubation of the H9c2 cells with various concentrations of tBHQ for 24 hours enhances cell viability which is decreased due to exposure to ethanol in a dose-dependent manner. Treatment with tBHQ markedly enhances the viability of H9c2 cardiomyocytes exposed to ethanol[3].
TBHQ (5 μM; 15 min; H9c2 cells) treatment significantly reduces the amount of apoptotic cells exposed to ethanol[3].
TBHQ (5 μM; H9c2 cells) pre-treatment markedly inhibites the ethanol-induced increase in caspase-3 and Bax expression, and enhances Bcl-2 expression[3].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:H9c2 cells
-
Concentration:0 µM, 0.625 µM, 1.25 µM, 2.5 µM, 5 µM, 10 µM, 20 µM, 50 µM and 100 µM
-
Incubation Time:48 hours
-
Result:Enhanced the viability of H9c2 cardiomyocytes exposed to ethanol.
-
Cell Line:H9c2 cells
-
Concentration:5 μM
-
Incubation Time:
-
Result:Lowered the amount of apoptotic cells exposed to ethanol.
-
Cell Line:H9c2 cells
-
Concentration:5 μM
-
Incubation Time:
-
Result:Inhibited the ethanol-induced increase in caspase-3 and Bax expression, and enhanced Bcl-2 expression.
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Male CD-1 mice (8-10 weeks old)[4]
-
Dosage:50 mg/kg
-
Administration:Intraperitoneal injection; three injections at intervals of 8 hours that began 1h post ICH.
-
Result:The treatment augmented the DNA-binding activity of Nrf2, attenuated brain oxidative damage, attenuated the microglial activation and the expression of IL-1β.
Chemical Information
-
CAS. Nr. 1948-33-0
-
Appearance Solid
-
Molecular Weight 166.22
-
Formel C10H14O2
-
Color White to off-white
-
SMILES
OC1=CC=C(O)C=C1C(C)(C)C
-
Synonyms
tert-Butylhydroquinone
-
Versand
Room temperature in continental US; may vary elsewhere.
-
Speicherung
Store at room temperature 3 years
In solvent -80°C 2 years -20°C 1 year
Publications (123)
-
Journal Impact Factor
-
Most Recent
-
Nat Commun
GRB2 regulation of essential signaling pathways in the endometrium is critical for implantation and decidualization. [Abstract]2025 Mar 4;16(1):2192. PMID: 40038241 -
Nat Commun
Regorafenib inhibits EphA2 phosphorylation and leads to liver damage via the ERK/MDM2/p53 axis. [Abstract]2023 May 13;14(1):2756. PMID: 37179400
TBHQ purchased from MedChemExpress. Usage Cited in: Nat Commun. 2023 May 13;14(1):2756. [Abstract]
TBHQ (20 μM; 24 h) activates ERK and modestly increases p-EphA2 (Ser897) levels in HL-7702 cells. However, when combined with regorafenib, TBHQ fails to rescue the inhibition of p-EphA2. Under TBHQ treatment, regorafenib still inhibits EphA2 phosphorylation and reduces p-ERK levels.
-
Nat Commun
Tenascin C+ papillary fibroblasts facilitate neuro-immune interaction in a mouse model of psoriasis. [Abstract]2023 Apr 10;14(1):2004. PMID: 37037861
TBHQ purchased from MedChemExpress. Usage Cited in: Nat Commun. 2023 Apr 10;14(1):2004. [Abstract]
TBHQ (1 μM) further promotes TNC (0.5 μg/mL)-induced neurite anomalous bifurcation.
-
Autophagy
2025 Feb;21(2):407-423. PMID: 39291751
TBHQ purchased from MedChemExpress. Usage Cited in: Autophagy. 2025 Feb;21(2):407-423. [Abstract]
RT-PCR to measure expression of NFE2L2 targets in A549 cells infected with WT or ΔS legionella for 6 h in presence of 10 µm tBHQ or ML385.
-
Adv Sci (Weinh)
PIP5K1A Suppresses Ferroptosis and Induces Sorafenib Resistance by Stabilizing NRF2 in Hepatocellular Carcinoma. [Abstract]2025 May 23:e04372. PMID: 40405713
TBHQ purchased from MedChemExpress. Usage Cited in: Adv Sci (Weinh). 2025 May 23:e04372. [Abstract]
Protein levels of NRF, PIP5K1A and NQO1 in Hep3B cells treated with tBHQ (TBHQ; 50 μm) or SFN (5 μm) for 24h.
-
Theranostics
Covalent modification of Keap1 at Cys77 and Cys434 by pubescenoside a suppresses oxidative stress-induced NLRP3 inflammasome activation in myocardial ischemia-reperfusion injury. [Abstract]2021 Jan 1;11(2):861-877. PMID: 33391509 -
-
J Adv Res
Extracellular vesicles derived from Lactobacillus johnsonii promote gut barrier homeostasis by enhancing M2 macrophage polarization. [Abstract]2025 Mar:69:545-563. PMID: 38508446 -
J Nanobiotechnology
Reciprocal regulation of NRF2 by autophagy and ubiquitin-proteasome modulates vascular endothelial injury induced by copper oxide nanoparticles. [Abstract]2022 Jun 11;20(1):270. PMID: 35690781
TBHQ purchased from MedChemExpress. Usage Cited in: J Nanobiotechnology. 2022 Jun 11;20(1):270. [Abstract]
Immunoblotting analysis and quantification of NRF2 half-life in CuONPs-treated WT or ATG5-KO HUVECs cells. Cells were treated with TBHQ (tBHQ; 10 μM) and CuONPs (20 μg/ml) for 9 h, and then treated with CHX (50 μg/ml) for 0, 1, 2, 3, 6, 9 h, respectively. β-Actin served as loading control.
-
Sci Adv
Direct recruitment of TONSOKU by the N-terminal tails of histone variants H2A.X and H2A.W coordinates DNA repair. [Abstract]2025 Dec 19;11(51):eady2104. PMID: 41406205 -
Redox Biol
Quercetin ameliorates oxidative stress in BMP15-deficient oocytes by regulating the ERK1/2-GSK3β-CypD pathway. [Abstract]2025 Nov:87:103886. PMID: 41086612 -
Redox Biol
Cathepsin S regulates ferroptosis sensitivity in hepatocellular carcinoma through the KEAP1-NRF2 signaling pathway. [Abstract]2025 Aug 6:86:103815. PMID: 40784043 -
Redox Biol
Nrf2/Nlrp3 signaling in aging BMSCs: Traf6 intervention as a novel approach to osteoporosis treatment. [Abstract]2025 Oct:86:103804. PMID: 40768898 -
Redox Biol
Acute lymphoblastic leukemia necessitates GSH-dependent ferroptosis defenses to overcome FSP1-epigenetic silencing. [Abstract]2022 Jul 31;55:102408. PMID: 35944469 -
J Immunother Cancer
Spatial and single-cell transcriptomics reveal cellular heterogeneity and a novel cancer-promoting Treg cell subset in human clear-cell renal cell carcinoma. [Abstract]2025 Jan 4;13(1):e010183. PMID: 39755578 -
Pharmacol Res
Cyclopeptide RA-V from Rubia yunnanensis restores activity of Adagrasib against colorectal cancer by reducing the expression of Nrf2. [Abstract]2024 Jun 28:107252. PMID: 38945380 -
J Neuroinflammation
Nrf-2 signaling inhibits intracranial aneurysm formation and progression by modulating vascular smooth muscle cell phenotype and function. [Abstract]2019 Oct 4;16(1):185. PMID: 31585542 -
Int J Biol Sci
4-Octyl itaconate regulates immune balance by activating Nrf2 and negatively regulating PD-L1 in a mouse model of sepsis. [Abstract]2022 Oct 24;18(16):6189-6209. PMID: 36439878 -
Cell Death Dis
ELANE enhances KEAP1 protein stability and reduces NRF2-mediated ferroptosis inhibition in metabolic dysfunction-associated fatty liver disease. [Abstract]2025 Apr 9;16(1):266. PMID: 40204709 -
Cell Death Dis
The USP11/Nrf2 positive feedback loop promotes colorectal cancer progression by inhibiting mitochondrial apoptosis. [Abstract]2024 Dec 1;15(12):873. PMID: 39617751 -
Cell Death Dis
UBE2E2 enhances Snail-mediated epithelial-mesenchymal transition and Nrf2-mediated antioxidant activity in ovarian cancer. [Abstract]2023 Feb 10;14(2):100. PMID: 36765041 -
Cell Death Dis
Ammonium tetrathiomolybdate triggers autophagy-dependent NRF2 activation in vascular endothelial cells. [Abstract]2022 Aug 25;13(8):733. PMID: 36008391 -
J Cachexia Sarcopenia Muscle
Unravelling the Role of PIEZO1 in Adipogenesis of Fibrogenic/Adipogenic Progenitors for Muscle Fat Infiltration After Rotator Cuff Tear. [Abstract]2025 Aug;16(4):e70004. PMID: 40726363 -
Proc Natl Acad Sci U S A
2019 Feb 19;116(8):2996-3005. PMID: 30718432 -
Cell Commun Signal
Vitamin D impedes eosinophil chemotaxis via inhibiting glycolysis-induced CCL26 expression in eosinophilic chronic rhinosinusitis with nasal polyps. [Abstract]2025 Feb 21;23(1):104. PMID: 39985085 -
Int J Biol Macromol
Carboxymethyl Poria cocos polysaccharides protect against septic kidney injury by regulating the Nrf2-NF-κB signaling pathway. [Abstract]2025 Apr 9:143030. PMID: 40216133 -
Int J Biol Macromol
MiR-221 on protective oxidative induced by selenium modified Codonopsis pilosula polysaccharide. [Abstract]2024 Aug 16:134815. PMID: 39154690 -
Int J Biol Macromol
2024 May;266(Pt 1):130939. PMID: 38493816 -
Acta Pharmacol Sin
A novel FAK-degrading PROTAC molecule exhibited both anti-tumor activities and efficient MDR reversal effects. [Abstract]2024 Oct;45(10):2174-2185. PMID: 38844788 -
Phytomedicine
Targeting the smooth muscle cell KEAP1-Nrf2-STING axis with pterostilbene attenuates abdominal aortic aneurysm. [Abstract]2024 May 10:130:155696. PMID: 38763007 -
Phytomedicine
Ginsenoside CK targeting KEAP1-DGR/Kelch domain disrupts the binding between KEAP1 and NRF2-DLG motif to ameliorate oxidative stress damage. [Abstract]2023 Oct:119:154992. PMID: 37499433 -
Phytomedicine
Damnacanthal isolated from morinda species inhibited ovarian cancer cell proliferation and migration through activating autophagy. [Abstract]2022 Jun;100:154084. PMID: 35421676 -
Free Radic Biol Med
Baicalein attenuates metabolic dysfunction-associated steatohepatitis by regulating macrophage ferroptosis through nuclear factor (erythroid-derived 2)-like 2 pathway. [Abstract]2025 Aug 11:240:238-252. PMID: 40803417 -
Free Radic Biol Med
Sestrin2 reduces ferroptosis via the Keap1/Nrf2 signaling pathway after intestinal ischemia-reperfusion. [Abstract]2024 Mar:214:115-128. PMID: 38331008 -
Free Radic Biol Med
A novel crosstalk between Nrf2 and Smad2/3 bridged by two nuanced Keap1 isoforms with their divergent effects on these distinct family transcription factors. [Abstract]2024 Mar:213:190-207. PMID: 38242246 -
Free Radic Biol Med
The role of ferroptosis mediated by Bmal1/Nrf2 in nicotine -induce injury of BTB integrity. [Abstract]2023 May 1:200:26-35. PMID: 36893944 -
Regen Biomater
Inhibition effect of copper-bearing metals on arterial neointimal hyperplasia via the AKT/Nrf2/ARE pathway in vitro and in vivo. [Abstract]2024 Apr 16:11:rbae042. PMID: 39027361 -
NPJ Sci Food
Lycopene mitigates T-2 toxin-induced hepatic ferroptosis by targeting the Nrf2/mitophagy axis in mice. [Abstract]2026 Feb 7;10(1):94. PMID: 41654705 -
Br J Pharmacol
Tert-butylhydroquinone promotes skin flap survival by inhibiting oxidative stress mediated by the Nrf2/HO-1 signalling pathway. [Abstract]2024 Dec;181(23):4845-4858. PMID: 39233316 -
Environ Res
The effect and mechanism of combined exposure of MC-LR and NaNO2 on liver lipid metabolism. [Abstract]2024 May 8;252(Pt 4):119113. PMID: 38729410 -
J Transl Med
Identification of RECK as a protective prognostic indicator and a tumor suppressor through regulation of the ERK/MAPK signaling pathway in gastric cancer. [Abstract]2023 Oct 30;21(1):766. PMID: 37904179 -
Biomed Pharmacother
Protective activity of tert-butylhydroquinone against oxidative stress and apoptosis induced by glutamate agonizts in R28 cells and mice retina. [Abstract]2022 Aug:152:113117. PMID: 35653886 -
Redox Rep
Kaempferol protects against doxorubicin-induced myocardial damage by inhibiting mitochondrial ROS-dependent ferroptosis. [Abstract]2025 Dec;30(1):2503130. PMID: 40361284 -
Int J Radiat Oncol Biol Phys
Combined Aurora Kinase A and CHK1 Inhibition enhances radiosensitivity of triple-negative breast cancer through induction of apoptosis and mitotic catastrophe associated with excessive DNA damage. [Abstract]2023 Dec 1;117(5):1241-1254. PMID: 37393021 -
J Agric Food Chem
Nrf2 Promotes BHBA-Induced Pyroptosis in Bovine Endometrial Epithelial Cells by Modulating Autophagy Mediated through Oxidative Stress. [Abstract]2025 Oct 24. PMID: 41134715 -
Cell Mol Life Sci
EphA2 promotes the transcription of KLF4 to facilitate stemness in oral squamous cell carcinoma. [Abstract]2024 Jun 25;81(1):278. PMID: 38916835 -
J Agric Food Chem
Round Scad-Derived Octapeptide WCPFSRSF Confers Neuroprotection by Regulating Akt/Nrf2/NFκB Signaling. [Abstract]2021 Sep 15;69(36):10606-10616. PMID: 34482683 -
Ecotoxicol Environ Saf
The activation of SIRT1-Nrf2 axis exerts beneficial effects against rotenone-induced cognitive deficits in mice through inhibition of neuroinflammation and ferroptosis. [Abstract]2026 Jan 1:309:119697. PMID: 41529472 -
Ecotoxicol Environ Saf
Methionine alleviates heat stress-induced ferroptosis in bovine mammary epithelial cells through the Nrf2 pathway. [Abstract]2023 May:256:114889. PMID: 37079940 -
Cell Prolif
Optineurin Cooperates With NRF2 to Regulate Tooth Root Morphogenesis by Controlling Mitochondrial Dynamics and Apoptosis. [Abstract]2025 Jan 6:e13799. PMID: 39762159 -
Biochem Pharmacol
Schisantherin A induces cell apoptosis through ROS/JNK signaling pathway in human gastric cancer cells. [Abstract]2020 Mar;173:113673. PMID: 31629709 -
J Dent
Metformin's mechanism in reducing oxidative stress and promoting bone regeneration in T2DM rat BMMSCs: A focus on NRF2-GPX7 signaling pathway. [Abstract]2025 Apr 28:105787. PMID: 40306480 -
J Ethnopharmacol
Multi-technology integrated network pharmacology-based study on phytochemicals, active metabolites, and molecular mechanism of Psoraleae Fructus to promote melanogenesis. [Abstract]2024 May 10:325:117755. PMID: 38218502 -
J Ethnopharmacol
Mercury-containing preparations attenuate neutrophil extracellular trap formation in mice and humans through inhibiting the ERK1/2 pathway. [Abstract]2024 Mar 1:321:117421. PMID: 37979820 -
-
Drug Des Devel Ther
Andrographolide Inhibits Static Mechanical Pressure-Induced Intervertebral Disc Degeneration via the MAPK/Nrf2/HO-1 Pathway. [Abstract]2023 Feb 20:17:535-550. PMID: 36845666 -
Life Sci
Intermittent hypoxia aggravates non-alcoholic fatty liver disease via RIPK3-dependent necroptosis-modulated Nrf2/NFκB signaling pathway. [Abstract]2021 Nov 15:285:119963. PMID: 34536498 -
Int J Mol Sci
2023 Sep 18;24(18):14215. PMID: 37762517 -
Int J Mol Sci
Plectin Downregulation Inhibits Migration and Suppresses Epithelial Mesenchymal Transformation of Hepatocellular Carcinoma Cells via ERK1/2 Signaling. [Abstract]2022 Dec 21;24(1):73. PMID: 36613521 -
Pharm Biol
β-Hydroxyisovalerylshikonin regulates macrophage polarization via the AMPK/Nrf2 pathway and ameliorates sepsis in mice. [Abstract]2022 Dec;60(1):729-742. PMID: 35352622 -
Front Pharmacol
Nrf2 Is a Key Regulator on Puerarin Preventing Cardiac Fibrosis and Upregulating Metabolic Enzymes UGT1A1 in Rats. [Abstract]2018 Jun 6:9:540. PMID: 29928229
TBHQ purchased from MedChemExpress. Usage Cited in: Front Pharmacol. 2018 Jun 6:9:540. [Abstract]
BHQ promotes higher protein expression of Nrf2 in a time-dependent manner in neonatal rat cardiac fibroblasts (NRCF) while notably downregulated collagen I and collagen III.
-
Int Immunopharmacol
TMEM176A drives anti-apoptotic signaling through TGM2-mediated ERK activation in gastric cancer. [Abstract]2025 Nov 8;168(Pt 1):115798. PMID: 41207103 -
Int Immunopharmacol
Ozone rectal insufflation attenuates lung inflammation by inhibiting the TLR4/NF-κB pathway through upregulation of Nrf2 in mice with COPD-like pathology. [Abstract]2025 Oct 19:167:115676. PMID: 41115352 -
Int Immunopharmacol
tBHQ mitigates fatty liver ischemia-reperfusion injury by activating Nrf2 to attenuate hepatocyte mitochondrial damage and macrophage STING activation. [Abstract]2024 Jun 24:138:112515. PMID: 38917524 -
Int Immunopharmacol
Glycyrrhizin protects against particulate matter-induced lung injury via regulation of endoplasmic reticulum stress and NLRP3 inflammasome-mediated pyroptosis through Nrf2/HO-1/NQO1 signaling pathway. [Abstract]2023 Jul:120:110371. PMID: 37245303 -
Int Immunopharmacol
S100a8/a9 contributes to sepsis-induced cardiomyopathy by activating ERK1/2-Drp1-mediated mitochondrial fission and respiratory dysfunction. [Abstract]2023 Feb:115:109716. PMID: 36652759 -
Molecules
Silencing LY6D Expression Inhibits Colon Cancer in Xenograft Mice and Regulates Colon Cancer Stem Cells' Proliferation, Stemness, Invasion, and Apoptosis via the MAPK Pathway. [Abstract]2023 Nov 25;28(23):7776. PMID: 38067506 -
J Inflamm Res
Systemic Lupus Erythematosus Stimulates Chondrocyte Pyroptosis to Aggravate Arthritis via Suppression of NRF-2/KEAP-1 and NF-κB Pathway. [Abstract]2025 Mar 20:18:4233-4250. PMID: 40129871 -
J Inflamm Res
The Onset of Systemic Lupus Erythematosus Triggers Nucleus Pulposus Cell Pyroptosis to Exacerbate Intervertebral Disc Degeneration. [Abstract]2024 Oct 25:17:7705-7719. PMID: 39473981 -
-
Sci Rep
The ferroptotic effect of NRF2-GCLM signaling axis derived by radiotherapy of esophageal squamous cell cancer: the vivo study. [Abstract]2025 Jul 24;15(1):26917. PMID: 40707557 -
Sci Rep
ADCY4 inhibits cAMP-induced growth of breast cancer by inactivating FAK/AKT and ERK signaling but is frequently silenced by DNA methylation. [Abstract]2025 Jul 1;15(1):20426. PMID: 40594405 -
J Virol
Seneca Valley virus 3C protease targets the Nrf2/HO-1 pathway to antagonize its antiviral activity. [Abstract]2026 Feb 17;100(2):e0165625. PMID: 41489372 -
ACS Infect Dis
The Outer Membrane Protein Tp92 of Treponema pallidum Induces BeWo Cells Apoptosis and Oxidative Stress via the Nrf2/keap1 Pathway. [Abstract]2025 Aug 19. PMID: 40830074 -
Food Sci Nutr
Psoralen and Isopsoralen Activate Nuclear Factor Erythroid 2-Related Factor 2 Through Interaction With Kelch-Like ECH-Associated Protein 1. [Abstract]2025 Jan 24;13(1):e4768. PMID: 39867839 -
Virol J
Upregulation of nuclear factor E2-related factor 2 (Nrf2) represses the replication of herpes simplex virus type 1. [Abstract]2022 Jan 31;19(1):23. PMID: 35101046 -
Cell Signal
CX-5461 inhibits cell proliferation and induces ferroptosis of colorectal cancer cells by inactivating Nrf2 pathway. [Abstract]2025 Nov:135:111998. PMID: 40664345 -
Cell Signal
RLIG1 promotes triple-negative breast cancer proliferation by activating mTORC1 signal pathway by interacting with ERK. [Abstract]2025 Jun 27:111969. PMID: 40582436 -
Eur J Immunol
CKBA suppresses mast cell activation via ERK signaling pathway in murine atopic dermatitis. [Abstract]2023 Sep;53(9):e2350374. PMID: 37417726 -
PLoS Comput Biol
An integrative analysis reveals the mechanism of plastic stabilizers inducing breast cancer. [Abstract]2026 Mar 6;22(3):e1014025. PMID: 41790613 -
Vet Res
GSK3β-mediated NRF2 degradation drives Escherichia coli-induced ferroptosis in the bovine endometrium. [Abstract]2025 Dec 18;56(1):232. PMID: 41413615 -
Mol Med Rep
Upregulation of antioxidant and autophagy pathways via NRF2 activation protects spinal cord neurons from ozone damage. [Abstract]2021 Jun;23(6):428. PMID: 33846774 -
Viruses
Generation of a Reassortant Influenza A Subtype H3N2 Virus Expressing Gaussia Luciferase. [Abstract]2019 Jul 20;11(7):665. PMID: 31330768 -
Toxicol Appl Pharmacol
Myricetin inhibits 4 T1 breast tumor growth in mice via induction of Nrf-2/GPX4 pathway-mediated Ferroptosis. [Abstract]2024 Jun 3:116990. PMID: 38838791 -
BMC Complement Med Ther
Neuroprotective effect of acetoxypachydiol against oxidative stress through activation of the Keap1-Nrf2/HO-1 pathway. [Abstract]2024 Apr 25;24(1):175. PMID: 38664646 -
Nanotoxicology
Stabilization of Nrf2 leading to HO-1 activation protects against zinc oxide nanoparticles-induced endothelial cell death. [Abstract]2021 Aug;15(6):779-797. PMID: 33971103 -
Eur J Med Res
LncRNA NEAT1 promotes nucleus pulposus cell matrix degradation through regulating Nrf2/ARE axis. [Abstract]2021 Jan 21;26(1):11. PMID: 33478594 -
Neurotox Res
p-Nrf2/HO-1 Pathway Involved in Methamphetamine-induced Executive Dysfunction through Endoplasmic Reticulum Stress and Apoptosis in the Dorsal Striatum. [Abstract]2023 Oct;41(5):446-458. PMID: 37199892 -
Int J Med Sci
Gemcitabine and XCT790, an ERRα inverse agonist, display a synergistic anticancer effect in pancreatic cancer. [Abstract]2022 Jan 4;19(2):286-298. PMID: 35165514 -
Vet J
Pinobanksin alleviates 4℃ semen preservation-induced oxidative damage and apoptosis in Wenchang Pig spermatozoa via the CaMKKβ/AMPK/Nrf2 pathway. [Abstract]2026 Apr:316:106599. PMID: 41698643 -
Cancer Med
Tetrandrine sensitizes nasopharyngeal carcinoma cells to irradiation by inducing autophagy and inhibiting MEK/ERK pathway. [Abstract]2020 Oct;9(19):7268-7278. PMID: 32780562 -
Mol Immunol
ANXA3 interference inactivates ERK/ELK1 pathway to mitigate inflammation and apoptosis in sepsis-associated acute lung injury. [Abstract]2024 Mar:167:25-33. PMID: 38310670 -
Toxicol Lett
Oxidative injury induced by drinking water disinfection by-products dibromoacetonitrile and dichloroacetonitrile in mouse hippocampal neuronal cells: The protective effect of N-acetyl-L-cysteine. [Abstract]2022 Jul 15:365:61-73. PMID: 35724848 -
Neuroscience
Inhibition of TRPA1 Attenuates Oxidative Stress-induced Damage After Traumatic Brain Injury via the ERK/AKT Signaling Pathway. [Abstract]2022 Jul 1:494:51-68. PMID: 35158017 -
Onco Targets Ther
Dehydrocorydaline inhibits cell proliferation, migration and invasion via suppressing MEK1/2-ERK1/2 cascade in melanoma. [Abstract]2019 Jul 2:12:5163-5175. PMID: 31456643 -
Cell Biochem Funct
2024 Jun;42(4):e4024. PMID: 38666564 -
PLoS One
Suppression of migration and invasion by taraxerol in the triple-negative breast cancer cell line MDA-MB-231 via the ERK/Slug axis. [Abstract]2023 Sep 26;18(9):e0291693. PMID: 37751436 -
Brain Res
TBHQ improved neurological recovery after traumatic brain injury by inhibiting the overactivation of astrocytes. [Abstract]2020 Jul 15;1739:146818. PMID: 32275911 -
Cell Biochem Biophys
Impairing Ferroptosis Through the PI3K/Akt/Nrf2 Pathway: The Way for Nerve Growth Factor to Mitigate Hypoxia-induced Cardiomyocyte Damage. [Abstract]2025 Jun;83(2):2023-2033. PMID: 39549229 -
Tissue Cell
FNDC4 reduces inflammation, proliferation, invasion and migration of rheumatoid synovial cells by inhibiting CCL2/ERK signaling. [Abstract]2024 Feb:86:102294. PMID: 38181585 -
Clin Res Hepatol Gastroenterol
ZFX promotes tumorigenesis and confers chemotherapy resistance in esophageal squamous cell carcinoma. [Abstract]2021 Sep;45(5):101586. PMID: 33662636 -
Int J Exp Pathol
Exosomal miR-221-3p derived from bone marrow mesenchymal stem cells alleviates endoplasmic reticulum stress-mediated apoptosis in nucleus pulposus cells via the Nrf2/HO-1 signalling pathway. [Abstract]2025 Nov;106(6):e70008. PMID: 41201370 -
Biochem Biophys Res Commun
Knockdown of MTHFD2 inhibits proliferation and migration of nasopharyngeal carcinoma cells through the ERK signaling pathway. [Abstract]2022 Jul 23:614:47-55. PMID: 35567943 -
Oncol Lett
Melatonin inhibits gallbladder cancer cell migration and invasion via ERK-mediated induction of epithelial-to-mesenchymal transition. [Abstract]2021 Aug;22(2):609. PMID: 34188711 -
Biochem Bioph Res Co
POU4F1 confers trastuzumab resistance in HER2-positive breast cancer through regulating ERK1/2 signaling pathway. [Abstract]2020 Dec 10;533(3):533-539. PMID: 32988584 -
Biochem Biophys Res Commun
Bruceine D elevates Nrf2 activation to restrain Parkinson's disease in mice through suppressing oxidative stress and inflammatory response. [Abstract]2020 Jun 11;526(4):1013-1020. PMID: 32321640 -
Biochem Biophys Res Commun
Nrf2 activation protects against intratracheal LPS induced mouse/murine acute respiratory distress syndrome by regulating macrophage polarization. [Abstract]2018 Jun 7;500(3):790-796. PMID: 29684352
TBHQ purchased from MedChemExpress. Usage Cited in: Biochem Biophys Res Commun. 2018 Jun 7;500(3):790-796. [Abstract]
Macrophages are isolated from wild-type mice, treated with tBHQ (100 μM) or not, and induced for 3 h using LPS, IFN-g, IL-4 or IL-13. Western blot analysis of the expression of Nrf2, p65 subunit of NF-kB, phosphorylated p65 and PPARg in the cytoplasm and nucleus.
-
Eur J Histochem
Transcription factor nuclear factor erythroid 2 p45-related factor 2 (NRF2) ameliorates sepsis-associated acute kidney injury by maintaining mitochondrial homeostasis and improving the mitochondrial function. [Abstract]2022 Jun 21;66(3). PMID: 35726572 -
-
J Environ Sci (China)
Multifunctional assays and molecular simulations reveal the protective mechanisms of QNZ in mitigating PFOA-induced cytotoxicity in Nthy-ori3-1 cells. [Abstract]2026 Mar:161:201-208. PMID: 41461467 -
-
-
-
-
-
-
-
-
-
Oxid Med Cell Longev
High Level of Uric Acid Promotes Atherosclerosis by Targeting NRF2-Mediated Autophagy Dysfunction and Ferroptosis. [Abstract]2022 Apr 18;2022:9304383. PMID: 35480874 -
Oxid Med Cell Longev
Promoting Nrf2/Sirt3-Dependent Mitophagy Suppresses Apoptosis in Nucleus Pulposus Cells and Protects against Intervertebral Disc Degeneration. [Abstract]2021 Jun 9:2021:6694964. PMID: 34211633 -
-
Oxid Med Cell Longev
Apatinib, a Novel Tyrosine Kinase Inhibitor, Promotes ROS-Dependent Apoptosis and Autophagy via the Nrf2/HO-1 Pathway in Ovarian Cancer Cells. [Abstract]2020 May 13;2020:3145182. PMID: 32509141
Lösungsmittel & Löslichkeit
DMSO : ≥ 56.66 mg/mL (340.87 mM; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
* "≥" means soluble, but saturation unknown.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 2 years; -20°C, 1 year. When stored at -80°C, please use it within 2 years. When stored at -20°C, please use it within 1 year.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 2 years; -20°C, 1 year. When stored at -80°C, please use it within 2 years. When stored at -20°C, please use it within 1 year.
Konzentration (Stammlösung) × Volumen (Stammlösung) = Konzentration (Ziellösung) × Volumen (Ziellösung)
Select the appropriate dissolution method based on your experimental animal and administration route.
- For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:
- To ensure reliable experimental results, the clarified stock solution can be appropriately stored based on storage conditions. As for the working solution for In Vivo experiments, it is recommended to prepare freshly and use it on the same day.
- The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.
Add each solvent one by one: 10% DMSO 40% PEG300 5% Tween-80 45% Saline
Solubility: ≥ 2.5 mg/mL (15.04 mM); Clear solution
This protocol yields a clear solution of ≥ 2.5 mg/mL (saturation unknown).
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 400 μL PEG300, and mix evenly; then add 50 μL Tween-80 and mix evenly; then add 450 μL Saline to adjust the volume to 1 mL.
Preparation of Saline: Dissolve 0.9 g sodium chloride in ddH₂O and dilute to 100 mL to obtain a clear Saline solution.
Add each solvent one by one: 10% DMSO 90% (20% SBE-β-CD in Saline)
Solubility: ≥ 2.5 mg/mL (15.04 mM); Clear solution
This protocol yields a clear solution of ≥ 2.5 mg/mL (saturation unknown).
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 900 μL 20% SBE-β-CD in Saline, and mix evenly.
Preparation of 20% SBE-β-CD in Saline (4°C, storage for one week): 2 g SBE-β-CD powder is dissolved in 10 mL Saline, completely dissolve until clear.
For the following dissolution methods, please prepare the working solution directly:
It is recommended to prepare fresh solutions and use them promptly within a short period of time.
The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.
Add each solvent one by one: 50% PEG300 50% Saline
Solubility: 20 mg/mL (120.32 mM); Clear solution; Need ultrasonic
Please enter the basic information of animal experiments:
-
-
-
-
Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
Please enter your animal formula composition:
-
%DMSO +
Recommended: Keep the proportion of DMSO in working solution below 2% if your animal is weak.
-
%+
-
+%Tween-80 + +
-
%Saline +
The co-solvents required include: DMSO, . All of co-solvents are available by MedChemExpress (MCE). , Tween 80. All of co-solvents are available by MedChemExpress (MCE).
Working solution concentration: 0.22 mg/mL
Method for preparing stock solution: mg drug dissolved in μL DMSO. Stock solution concentration: mg/mL.
1. Take μL DMSO stock solution;
2. Add μL .
μL , mix evenly;
3. Then add μL Tween 80, mix evenly;
4. Then add μL
Please ensure that the stock solution in the first step is dissolved to a clear state, and add co-solvents in sequence. You can use ultrasonic heating (ultrasonic cleaner, recommended frequency 20-40 kHz), vortexing, etc. to assist dissolution.
Reinheit & Dokumentation
-
Data Sheet (280 KB)
-
SDS (597 KB)
- English - EN (597 KB)
- Français - FR (597 KB)
- Deutsch - DE (597 KB)
- Norwegian - NO (597 KB)
- Español - ES (597 KB)
- Swedish - SV (597 KB)
- Italian - IT (597 KB)
- Portuguese - PT (597 KB)
-
Handling Instructions (2659 KB)
Verweise
[1]. Lin-Feng Wang, et al. Tert-butylhydroquinone ameliorates doxorubicin-induced cardiotoxicity by activating Nrf2 and inducing the expression of its target genes. Am J Transl Res. 2015; 7(10): 1724–1735. [Content Brief]
[2]. XIAOJING SHI, et al. Tert-butylhydroquinone attenuates the ethanol-induced apoptosis of and activates the Nrf2 antioxidant defense pathway in H9c2 cardiomyocytes.Int J Mol Med. 2016 Jul; 38(1): 123–130. [Content Brief]
[3]. Hu H, et al. Dehydrocorydaline inhibits cell proliferation, migration and invasion via suppressing MEK1/2-ERK1/2 cascade in melanoma.Onco Targets Ther. 2019 Jul 2;12:5163-5175. [Content Brief]
[4]. Sukumari-Ramesh S, et al. Post-Injury Administration of Tert-butylhydroquinone Attenuates Acute Neurological Injury AfterIntracerebral Hemorrhage in Mice.J Mol Neurosci. 2016 Apr;58(4):525-31. [Content Brief]
Complete Stock Solution Preparation Table
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 2 years; -20°C, 1 year. When stored at -80°C, please use it within 2 years. When stored at -20°C, please use it within 1 year.
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| DMSO | 1 mM | 6.0161 mL | 30.0806 mL | 60.1612 mL | 150.4031 mL |
| 5 mM | 1.2032 mL | 6.0161 mL | 12.0322 mL | 30.0806 mL | |
| 10 mM | 0.6016 mL | 3.0081 mL | 6.0161 mL | 15.0403 mL | |
| 15 mM | 0.4011 mL | 2.0054 mL | 4.0107 mL | 10.0269 mL | |
| 20 mM | 0.3008 mL | 1.5040 mL | 3.0081 mL | 7.5202 mL | |
| 25 mM | 0.2406 mL | 1.2032 mL | 2.4064 mL | 6.0161 mL | |
| 30 mM | 0.2005 mL | 1.0027 mL | 2.0054 mL | 5.0134 mL | |
| 40 mM | 0.1504 mL | 0.7520 mL | 1.5040 mL | 3.7601 mL | |
| 50 mM | 0.1203 mL | 0.6016 mL | 1.2032 mL | 3.0081 mL | |
| 60 mM | 0.1003 mL | 0.5013 mL | 1.0027 mL | 2.5067 mL | |
| 80 mM | 0.0752 mL | 0.3760 mL | 0.7520 mL | 1.8800 mL | |
| 100 mM | 0.0602 mL | 0.3008 mL | 0.6016 mL | 1.5040 mL |